[go: up one dir, main page]

FI980947L - Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi - Google Patents

Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi Download PDF

Info

Publication number
FI980947L
FI980947L FI980947A FI980947A FI980947L FI 980947 L FI980947 L FI 980947L FI 980947 A FI980947 A FI 980947A FI 980947 A FI980947 A FI 980947A FI 980947 L FI980947 L FI 980947L
Authority
FI
Finland
Prior art keywords
zeaxanthin
stereoisomer
pure
treatment
macular degeneration
Prior art date
Application number
FI980947A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI980947A7 (fi
FI980947A0 (fi
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerrasantos
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of FI980947A0 publication Critical patent/FI980947A0/fi
Publication of FI980947L publication Critical patent/FI980947L/fi
Publication of FI980947A7 publication Critical patent/FI980947A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI980947A 1995-10-31 1996-10-30 Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi FI980947A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
PCT/US1996/017563 WO1997016175A1 (fr) 1995-10-31 1996-10-30 Stereo-isomere 3r-3'r pur de zeaxanthine pour traiter la degenerescence maculaire chez l'homme

Publications (3)

Publication Number Publication Date
FI980947A0 FI980947A0 (fi) 1996-10-30
FI980947L true FI980947L (fi) 1998-04-29
FI980947A7 FI980947A7 (fi) 1998-04-29

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980947A FI980947A7 (fi) 1995-10-31 1996-10-30 Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi

Country Status (14)

Country Link
JP (1) JPH10512594A (fr)
KR (1) KR100570251B1 (fr)
CN (1) CN1104235C (fr)
AR (1) AR004245A1 (fr)
AU (1) AU710634B2 (fr)
BR (1) BR9611488A (fr)
CZ (1) CZ297575B6 (fr)
FI (1) FI980947A7 (fr)
HU (1) HU223208B1 (fr)
NO (1) NO981698L (fr)
PL (1) PL185465B1 (fr)
RU (1) RU2197958C2 (fr)
WO (1) WO1997016175A1 (fr)
ZA (1) ZA969139B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) * 2005-01-21 2005-03-02 Promar As Compositions
EP1861078A2 (fr) * 2005-02-11 2007-12-05 Kalamazoo Holdings, Inc. Variété capsicum présentant une hyper-accumulation de zéaxanthine et produits dérivés de cette variété
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
CN115820455A (zh) * 2022-07-08 2023-03-21 江苏宜裕环保科技有限公司 一株三乙胺降解菌及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
US4026949A (en) * 1974-08-21 1977-05-31 Hoffmann-La Roche Inc. Optically active cyclohexane derivatives
DE69030817T2 (de) * 1989-08-30 1997-10-16 Applied Food Biotech Inc Verfahren zur Herstellung einer Zeaxanthin enthaltenden Zusammensetzung mittels eines Mikroorganismus der Spezies Flavobacterium multivorum
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
US5386063A (en) * 1993-06-16 1995-01-31 The Catholic University Of America Synthesis of (all-E)-2,7,-dimethylocta-2,4,6-triene-1,8-dial13 C4
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants

Also Published As

Publication number Publication date
KR19990067180A (ko) 1999-08-16
CN1104235C (zh) 2003-04-02
HUP9802314A2 (hu) 1999-04-28
AR004245A1 (es) 1998-11-04
KR100570251B1 (ko) 2006-06-21
CZ130998A3 (cs) 1998-07-15
WO1997016175A1 (fr) 1997-05-09
RU2197958C2 (ru) 2003-02-10
FI980947A7 (fi) 1998-04-29
HUP9802314A3 (en) 1999-05-28
JPH10512594A (ja) 1998-12-02
AU7050196A (en) 1997-05-08
FI980947A0 (fi) 1996-10-30
HU223208B1 (hu) 2004-03-29
CN1201388A (zh) 1998-12-09
ZA969139B (en) 1997-09-25
NO981698L (no) 1998-06-08
NO981698D0 (no) 1998-04-16
MX9605248A (es) 1998-06-30
PL326558A1 (en) 1998-09-28
CZ297575B6 (cs) 2007-02-07
AU710634B2 (en) 1999-09-23
PL185465B1 (pl) 2003-05-30
BR9611488A (pt) 1999-01-19

Similar Documents

Publication Publication Date Title
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
IL117793A0 (en) Method for the treatment of macular degeneration
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
FI960278A0 (fi) Anataasititaanidioksidin valmistusmenetelmä
AU2467395A (en) Novel ophthalmologic uses of protein c
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
FI964229A0 (fi) Menetelmä doksorubisiinin valmistamiseksi
FI980947L (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
AU5526196A (en) Compositions for the treatment of dandruff
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
AU5699396A (en) Compositions for the treatment of skin conditions
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
FI964410A7 (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delt a4-3-ketosteroidien kautta
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
FI964278A7 (fi) Menetelmä 5,6-dihydroksi-2-amino-1,2,3,4-tetrahydronaftaleenin johdann aisten valmistamiseksi
AU6662794A (en) Composition for the treatment of impaired hair growth
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
AU2671895A (en) Bisquinolines for the treatment of malaria
FI951441L (fi) Menetelmä 5-formyyliamino-pyrimidiinien valmistamiseksi
AU6295094A (en) Compositions for the treatment of eye diseases

Legal Events

Date Code Title Description
FD Application lapsed